Variant report
Variant | esv3385793 |
---|---|
Chromosome Location | chr4:97965729-97969127 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536495015 | chr4:97965746-97965747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536397101 | chr4:97965754-97965755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569300304 | chr4:97965765-97965766 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554635938 | chr4:97965879-97965880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573113065 | chr4:97965906-97965907 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534082857 | chr4:97965913-97965914 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189059073 | chr4:97965989-97965990 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559009774 | chr4:97965994-97965995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577433792 | chr4:97965996-97965997 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs151127736 | chr4:97966014-97966015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563324927 | chr4:97966022-97966023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575301551 | chr4:97966152-97966153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542751688 | chr4:97966157-97966158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10010641 | chr4:97966171-97966172 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs528317085 | chr4:97966182-97966183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544643813 | chr4:97966185-97966186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192718714 | chr4:97966198-97966199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs546736826 | chr4:97966208-97966209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183764664 | chr4:97966302-97966303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532462598 | chr4:97966310-97966311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188535022 | chr4:97966374-97966375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558694353 | chr4:97966375-97966376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536207897 | chr4:97966402-97966403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs72874654 | chr4:97966415-97966416 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs78448853 | chr4:97966420-97966421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142636649 | chr4:97966464-97966465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144626377 | chr4:97966527-97966528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541114301 | chr4:97966528-97966529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147867217 | chr4:97966530-97966531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs28520218 | chr4:97966557-97966558 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs111432610 | chr4:97966584-97966585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141668976 | chr4:97966719-97966720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181294541 | chr4:97966917-97966918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377177721 | chr4:97966949-97966950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574118849 | chr4:97966962-97966963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 19197363 | CNVD |
Melanoma | 20688739 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:97960000-97966000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr4:97964200-97965800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr4:97964200-97966000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
4 | chr4:97964400-97965800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr4:97965600-97967000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr4:97965800-97966200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr4:97965800-97966800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr4:97966000-97966600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
9 | chr4:97966000-97966600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr4:97966000-97967000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr4:97966000-97967000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |